Researchers have developed a new chip device that offers superior forensic blood residue detection compared to current methods such as the use of luminol.
A novel artificial intelligence and biosensor device has been developed to monitor if live cancer cells remain after chemotherapy treatment.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
A small implantable device using LEDs has been developed to treat bladder problems, with the potential to replace current medications and electronic stimulators.